Английская Википедия:Indacaterol/mometasone

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use American English Шаблон:Use dmy dates Шаблон:Infobox drug

Indacaterol/mometasone, sold under the brand name Atectura Breezhaler among others, is a fixed-dose combination medication for the treatment of asthma in adults and adolescents twelve years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2 agonists.[1]

The most common side effects include worsening of asthma and nasopharyngitis (inflammation in the nose and throat).[1] Other common side effects include upper respiratory tract infection (nose and throat infections) and headache.[1] Indacaterol/mometasone was approved for medical use in the European Union in May 2020,[1] and in Japan in June 2020.[2]

References

Шаблон:Reflist

External links

Шаблон:Adrenergic agonists Шаблон:Asthma and copd rx Шаблон:Glucocorticoids and antiglucocorticoids Шаблон:Glucocorticoid receptor modulators Шаблон:Portal bar Шаблон:Respiratory-system-drug-stub

  1. 1,0 1,1 1,2 1,3 Шаблон:Cite web Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  2. Шаблон:Cite press release